Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Trilck, Michaela ^a   Hübner, Rayk ^a   Seibler, Philip ^b   Klein, Christine ^b   Rolfs, Arndt ^a   Frech, Moritz J ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Induced pluripotent stem cells; Lysosomal storage disorder; Neural differentiation; Neural progenitor cells; Niemann Pick Type C1

Indexed keywords

CHOLESTEROL; FILIPIN; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ACTION POTENTIAL; ARTICLE; CELL ASSAY; CONTROLLED STUDY; EMBRYOID BODY; EXCITATORY POSTSYNAPTIC POTENTIAL; FIBROBLAST; GERM LAYER; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NIEMANN PICK DISEASE; NIEMANN PICK TYPE C1; NONHUMAN; ONCOGENE C MYC; PATCH CLAMP; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; RETROVIRUS; STEM CELL; TERATOMA;

CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPING; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUTATION; NIEMANN-PICK DISEASE, TYPE C; OCTAMER TRANSCRIPTION FACTOR-3; PROTO-ONCOGENE PROTEINS C-MYB; SOXB1 TRANSCRIPTION FACTORS;

EID: 84884173944     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-144     Document Type: Article

References (48)

1. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
2. Reprogramming of human somatic cells to pluripotency with defined factors. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ, Nature 2008 451 141 146 10.1038/nature06534 18157115
3. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L, Blood 2009 114 5473 5480 10.1182/blood-2009-04-217406 19797525
4. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Liu H, Ye Z, Kim Y, Sharkis S, Jang YY, Hepatology 2010 51 1810 1819 10.1002/hep.23626 20432258
5. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lindgren A, Conway AE, Clark AT, Goldman SA, Plath K, et al. Stem Cells 2009 27 806 811 10.1002/stem.31 19350680
6. Functional cardiomyocytes derived from human induced pluripotent stem cells. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ, Circ Res 2009 104 30 e41 10.1161/CIRCRESAHA.108.192237 19213953
7. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Zhang D, Jiang W, Liu M, Sui X, Yin X, Chen S, Shi Y, Deng H, Cell Res 2009 19 429 438 10.1038/cr.2009.28 19255591
8. Derivation of male germ cells from induced pluripotent stem cells in vitro and in reconstituted seminiferous tubules. Yang S, Bo J, Hu H, Guo X, Tian R, Sun C, Zhu Y, Li P, Liu P, Zou S, et al. Cell Prolif 2012 45 91 100 10.1111/j.1365-2184.2012.00811.x 22324506
9. Disease-specific induced pluripotent stem cells. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ, Cell 2008 134 877 886 10.1016/j.cell.2008.07.041 18691744
10. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, Huang-Doran I, Griffin J, Ahrlund-Richter L, Skepper J, et al. J Clin Invest 2010 120 3127 3136 10.1172/JCI43122 20739751
11. Modeling retinal degeneration using patient-specific induced pluripotent stem cells. Jin ZB, Okamoto S, Osakada F, Homma K, Assawachananont J, Hirami Y, Iwata T, Takahashi M, PLoS ONE 2011 6 17084 10.1371/journal.pone.0017084 21347327
12. Characterization of human Huntington's disease cell model from induced pluripotent stem cells. Zhang N, An MC, Montoro D, Ellerby LM, PLoS Curr 2010 2 RRN1193
13. Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells. Lemonnier T, Blanchard S, Toli D, Roy E, Bigou S, Froissart R, Rouvet I, Vitry S, Heard JM, Bohl D, Hum Mol Genet 2011 20 3653 3666 10.1093/hmg/ddr285 21685203
14. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Yokoo N, Baba S, Kaichi S, Niwa A, Mima T, Doi H, Yamanaka S, Nakahata T, Heike T, Biochem Biophys Res Commun 2009 387 482 488 10.1016/j.bbrc.2009.07.052 19615974
15. The genomic organization and polymorphism analysis of the human Niemann-Pick C1 gene. Morris JA, Zhang D, Coleman KG, Nagle J, Pentchev PG, Carstea ED, Biochem Biophys Res Commun 1999 261 493 498 10.1006/bbrc.1999.1070 10425213 (Pubitemid 29392504)
16. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, et al. Science 1997 277 228 231 10.1126/science.277.5323.228 9211849 (Pubitemid 27446076)
17. Topological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein. Davies JP, Ioannou YA, J Biol Chem 2000 275 24367 24374 10.1074/jbc.M002184200 10821832 (Pubitemid 30626526)
18. Niemann-Pick disease type C. Vanier MT, Orphanet J Rare Dis 2010 5 16 10.1186/1750-1172-5-16 20525256
19. Type C Niemann-Pick disease: lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol. Sokol J, Blanchette-Mackie J, Kruth HS, Dwyer NK, Amende LM, Butler JD, Robinson E, Patel S, Brady RO, Comly ME, et al. J Biol Chem 1988 263 3411 3417 3277970 (Pubitemid 18072801)
20. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, Pineda M, Sedel F, Topcu M, Vanier MT, et al. Mol Genet Metab 2009 98 152 165 10.1016/j.ymgme.2009.06.008 19647672
21. The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. Liscum L, Ruggiero RM, Faust JR, J Cell Biol 1989 108 1625 1636 10.1083/jcb.108.5.1625 2715172 (Pubitemid 19130495)
22. Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone. Zampieri S, Mellon SH, Butters TD, Nevyjel M, Covey DF, Bembi B, Dardis A, J Cell Mol Med 2009 13 3786 3796 10.1111/j.1582-4934.2008.00493.x 18774957
23. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE, Cell 2009 137 1213 1224 10.1016/j.cell.2009.03.049 19563754
24. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A, Ellison J, Ohno K, Rosenfeld MA, Tagle DA, et al. Science 1997 277 232 235 10.1126/science.277.5323.232 9211850 (Pubitemid 27446077)
25. Clinical, electrophysiological, and serum biochemical measures of progressive neurological and hepatic dysfunction in feline Niemann-Pick type C disease. Vite CH, Ding W, Bryan C, O'Donnell P, Cullen K, Aleman D, Haskins ME, Van Winkle T, Pediatr Res 2008 64 544 549 10.1203/PDR.0b013e318184d2ce 18614965
26. A drosophila model of the Niemann-Pick type C lysosome storage disease: dnpc1a is required for molting and sterol homeostasis. Huang X, Suyama K, Buchanan J, Zhu AJ, Scott MP, Development 2005 132 5115 5124 10.1242/dev.02079 16221727 (Pubitemid 41764021)
27. Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells. Karten B, Peake KB, Vance JE, Biochim Biophys Acta 2009 1791 659 670 10.1016/j.bbalip.2009.01.025 19416638
28. A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase. Pentchev PG, Gal AE, Booth AD, Omodeo-Sale F, Fouks J, Neumeyer BA, Quirk JM, Dawson G, Brady RO, Biochim Biophys Acta 1980 619 669 679 10.1016/0005-2760(80)90116-2 6257302 (Pubitemid 11201153)
29. Consequences of NPC1 and NPC2 loss of function in mammalian neurons. Walkley SU, Suzuki K, Biochim Biophys Acta 2004 1685 48 62 10.1016/j.bbalip. 2004.08.011 15465426 (Pubitemid 39311809)
30. A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient's skin. Bergamin N, Dardis A, Beltrami A, Cesselli D, Rigo S, Zampieri S, Domenis R, Bembi B, Beltrami CA, Orphanet J Rare Dis 2013 8 34 10.1186/1750-1172-8-34 23433359
31. Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1. Sun X, Marks DL, Park WD, Wheatley CL, Puri V, O'Brien JF, Kraft DL, Lundquist PA, Patterson MC, Pagano RE, et al. Am J Hum Genet 2001 68 1361 1372 10.1086/320599 11349231 (Pubitemid 32510612)
32. Mitochondrial parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. Seibler P, Graziotto J, Jeong H, Simunovic F, Klein C, Krainc D, J Neurosci 2011 31 5970 5976 10.1523/JNEUROSCI.4441-10.2011 21508222
33. Niemann-Pick type C disease: characterizing lipid levels in patients with variant lysosomal cholesterol storage. Tängemo C, Weber D, Theiss S, Mengel E, Runz H, J Lipid Res 2011 52 813 825 10.1194/jlr.P013524 21245028
34. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA, Nat Biotechnol 2008 26 795 797 10.1038/nbt1418 18568017 (Pubitemid 351961456)
35. Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Yao S, Sukonnik T, Kean T, Bharadwaj RR, Pasceri P, Ellis J, Mol Ther 2004 10 27 36 10.1016/j.ymthe.2004.04.007 15233939 (Pubitemid 38878146)
36. Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1. Ordonez MP, Roberts EA, Kidwell CU, Yuan SH, Plaisted WC, Goldstein LS, Hum Mol Genet 2012 21 2651 2662 10.1093/hmg/dds090 22437840
37. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Mayshar Y, Ben David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N, Cell Stem Cell 2010 7 521 531 10.1016/j.stem.2010.07.017 20887957
38. Analysis of embryoid bodies derived from human induced pluripotent stem cells as a means to assess pluripotency. Sheridan SD, Surampudi V, Rao RR, Stem Cells Int 2012 2012 738910 22550517
39. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Lensch MW, Schlaeger TM, Zon LI, Daley GQ, Cell Stem Cell 2007 1 253 258 10.1016/j.stem.2007.07.019 18371359 (Pubitemid 47355327)
40. Generation of a human neuronal stable cell model for Niemann-Pick C disease by RNA interference. Rodriguez-Pascau L, Coll MJ, Casas J, Vilageliu L, Grinberg D, JIMD Rep 2012 4 29 37 23430894
41. Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Elkabetz Y, Panagiotakos G, Al Shamy G, Socci ND, Tabar V, Studer L, Genes Dev 2008 22 152 165 10.1101/gad.1616208 18198334
42. NPC1 gene deficiency leads to lack of neural stem cell self-renewal and abnormal differentiation through activation of p38 mitogen-activated protein kinase signaling. Yang SR, Kim SJ, Byun KH, Hutchinson B, Lee BH, Michikawa M, Lee YS, Kang KS, Stem Cells 2006 24 292 298 10.1634/stemcells.2005-0221 16099992 (Pubitemid 44464797)
43. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Nicholas CR, Chen J, Tang Y, Southwell DG, Chalmers N, Vogt D, Arnold CM, Chen YJ, Stanley EG, Elefanty AG, et al. Cell Stem Cell 2013 12 573 586 10.1016/j.stem.2013.04.005 23642366
44. Human cortical interneurons take their time. Marin O, Cell Stem Cell 2013 12 497 499 10.1016/j.stem.2013.04.017 23642355
45. GABAergic and glycinergic IPSCs in ganglion cells of rat retinal slices. Protti DA, Gerschenfeld HM, Llano I, J Neurosci 1997 17 6075 6085 9236219 (Pubitemid 27329883)
46. Characterization of the spontaneous synaptic activity of amacrine cells in the mouse retina. Frech MJ, Perez-Leon J, Wassle H, Backus KH, J Neurophysiol 2001 86 1632 1643 11600626 (Pubitemid 32953214)
47. Cholesterol-dependent balance between evoked and spontaneous synaptic vesicle recycling. Wasser CR, Ertunc M, Liu X, Kavalali ET, J Physiol 2007 579 413 429 17170046 (Pubitemid 46351759)
48. Oxidative stress activates the c-Abl/p73 proapoptotic pathway in Niemann-Pick type C neurons. Klein A, Maldonado C, Vargas LM, Gonzalez M, Robledo F, Perez de Arce K, Munoz FJ, Hetz C, Alvarez AR, Zanlungo S, Neurobiol Dis 2011 41 209 218 10.1016/j.nbd.2010.09.008 20883783